Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Item
http://www.wikidata.org/entity/Q38274981
Relaxin attenuates aristolochic acid induced human tubular epithelial cell apoptosis in vitro by activation of the PI3K/Akt signaling pathway.An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix.Vitamin E (α‑tocopherol) ameliorates aristolochic acid‑induced renal tubular epithelial cell death by attenuating oxidative stress and caspase‑3 activation.Environmental toxin-induced acute kidney injury.Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.Effect of quercetin on the uptake and efflux of aristolochic acid I from Caco-2 cell monolayers.Update of aristolochic acid nephropathy in KoreaFermented Astragalus in diet altered the composition of fecal microbiota in broiler chickens
P2860

Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Item
http://www.wikidata.org/entity/Q38274981
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
@en
type
label
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
@en
prefLabel
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698